Vitamin C for preventing and treating tetanus

Cochrane Database of Systematic Reviews

Volumn 2013, Issue 11, 2013, Pages

  Hemilä, Harri ^a   Koivula, Teija ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ASCORBIC ACID; VITAMIN;

CASE FATALITY RATE; CLINICAL OUTCOME; CONTROLLED CLINICAL TRIAL (TOPIC); DISEASE SEVERITY; DRUG EFFECT; FRACTURE; GROUPS BY AGE; HOSPITAL INFECTION; HOSPITALIZATION; HUMAN; MORTALITY; PRIORITY JOURNAL; REVIEW; SYSTEMATIC REVIEW; TETANUS; VITAMIN SUPPLEMENTATION; ADOLESCENT; ADULT; AGE; BANGLADESH; CHILD; INFANT; PRESCHOOL CHILD;

ADOLESCENT; ADULT; AGE FACTORS; ASCORBIC ACID; BANGLADESH; CHILD; CHILD, PRESCHOOL; HUMANS; INFANT; TETANUS; VITAMINS;

EID: 84900775444     PISSN: 14651858     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD006665.pub3     Document Type: Review

References (62)

1. Jahan K. Letter from Professor Khursheed Jahan. 9 July 2007.
2. Jahan K, Ahmad K, Ali MA. Effect of ascorbic acid in the treatment of tetanus. Bangladesh Medical Research Council Bulletin 1984;10(1):24-8. [http://www.mv.helsinki.fi/home/hemila/CT/Jahan1984.pdf; PUBMED: 6466264]
3. Afshar M, Raju M, Ansell D, Bleck TP. Tetanus-a health threat after natural disasters in developing countries. Annals of Internal Medicine 2011;154(5):329-35. [DOI: 10.7326/0003-4819-154-5-201103010-00007; PUBMED: 21357910]
4. Ataro P, Mushatt D, Ahsan S. Tetanus: a review. Southern Medical Journal 2011;104(8):613-7. [DOI: 10.1097/SMJ.0b013e318224006d; PUBMED: 21886075]
5. Bjordahl PM, Helmer SD, Gosnell DJ, Wemmer GE, O'Hara WW, Milfeld DJ. Perioperative supplementation with ascorbic acid does not prevent atrial fibrillation in coronary artery bypass graft patients. American Journal of Surgery 2012;204(6):862-7. [DOI: 10.1016/j.amjsurg.2012.03.012; PUBMED: 23022248]
6. Briggs M. Vitamin C and infectious disease: a review of the literature and the results of a randomized, double-blind, prospective study over 8 years. In: Briggs MH editor(s). Recent Vitamin Research. Boca Raton, FL: CRC Press, 1984:39-82.
7. Büller Souto A, Lima C. Effect of vitamin C on Bacillus perfringensis toxin (see data extracted and analysed in Clemetson 2002 and in Hemilä 2006:115) [Action de la vitamine C sur la toxine du Bacillus perfringens]. Memorias do Instituto Butantan 1939;12:265-95 [in Portuguese]; 297-311 [in French; same data]. [http://www.mv.helsinki.fi/home/hemila/CT/Buller1939.pdf]
8. Cameron E, Pauling L. Supplemental ascorbate in the supportive treatment of cancer: Prolongation of survival times in terminal human cancer. Proceedings of the National Academy of Sciences of the USA 1976;73(10):3685-9. [DOI: 10.1073/pnas.73.10.3685; PUBMED: 1068480]
9. Campbell GD, Steinberg MH, Bower JD. Ascorbic acid-induced hemolysis in G-6-PD deficiency. Annals of Internal Medicine 1975;82(6):810. [http://www.mv.helsinki.fi/home/hemila/CC/Campbell1975.pdf; PUBMED: 1138591]
10. Carpenter KJ. The History of Scurvy and Vitamin C. Cambridge: Cambridge University Press, 1986.
11. Cathcart RF. Vitamin C, titrating to bowel tolerance, anascorbemia, and acute induced scurvy. Medical Hypotheses 1981;7(11):1359-76. [DOI: 10.1016/0306-9877(81)90126-2; PUBMED: 7321921]
12. CDC (Centers for Disease Control and Prevention). Tetanus. http://www.cdc.gov/vaccines/pubs/pinkbook/downloads/tetanus.pdf 2013.
13. Chakrabarti B, Banerjee S. Dehydroascorbic acid level in blood of patients suffering from various infectious diseases. Proceedings of the Society for Experimental Biology and Medicine 1955;88(4):581-3. [http://www.mv.helsinki.fi/home/hemila/CT/Chakrabarti1955.pdf; PUBMED: 14371706]
14. Clemetson CA. Barlow's disease. Medical Hypotheses 2002;59(1):52-6. [DOI: 10.1016/S0306-9877(02)00114-7; PUBMED: 12160680]
15. Cook NR, Albert CM, Gaziano JM, Zaharris E, MacFadyen J, Danielson E, et al. A randomized factorial trial of vitamins C and E and beta carotene in the secondary prevention of cardiovascular events in women: results from the Women's Antioxidant Cardiovascular Study. Archives of Internal Medicine 2007;167(15):1610-8. [DOI: 10.1001/archinte.167.15.1610; PUBMED: 17698683]
16. Daher EF, Abdulkader RC, Motti E, Marcondes M, Sabbaga E, Burdmann EA. Prospective study of tetanus-induced acute renal dysfunction: role of adrenergic overactivity. American Journal of Tropical Medicine and Hygiene 1997;57(5):610-4. [PUBMED: 9392604]
17. Demicheli V, Barale A, Rivetti A. Vaccines for women to prevent neonatal tetanus. Cochrane Database of Systematic Reviews 2013, Issue 5. [DOI: 10.1002/14651858.CD002959.pub3; PUBMED: 23728640]
18. Dey PK. Efficacy of vitamin C in counteracting tetanus toxin toxicity. Naturwissenschaften 1966;53(12):310. [PUBMED: 5986216]
19. Diliberto EJ Jr, Daniels AJ, Viveros OH. Multicompartmental secretion of ascorbate and its dual role in dopamine beta-hydroxylation. American Journal of Clinical Nutrition 1991;54(Suppl 6):1163S-72S. [PUBMED: 1962565]
20. Gergen PJ, McQuillan GM, Kiely M, Ezzati-Rice TM, Sutter RW, Virella G. A population-based serologic survey of immunity to tetanus in the United States. New England Journal of Medicine 1995;332(12):761-6. [DOI: 10.1056/NEJM199503233321201; PUBMED: 7862178]
21. Gibson K, Bonaventure Uwineza J, Kiviri W, Parlow J. Tetanus in developing countries: a case series and review. Canadian Journal of Anesthesia 2009;56(4):307-15. [DOI: 10.1007/s12630-009-9058-1; PUBMED: 19296192]
22. Glasziou P, Chalmers I, Rawlins M, McCulloch P. When are randomised trials unnecessary? Picking signal from noise. BMJ 2007;334(7589):349-51. [DOI: 10.1136/bmj.39070.527986.68; PUBMED: 17303884]
23. Hathcock JN, Azzi A, Blumberg J, Bray T, Dickinson A, Frei B, et al. Vitamins E and C are safe across a broad range of intakes. American Journal of Clinical Nutrition 2005;81(4):736-45. [PUBMED: 15817846]
24. Hemilä H. Do vitamins C and E affect respiratory infections?. [Dissertation] University of Helsinki, Helsinki, Finland 2006:5-9, 62-63, 112, 115.
25. Hemilä H, Chalker EB. Vitamin C for preventing and treating the common cold. Cochrane Database of Systematic Reviews 2013, Issue 1. [DOI: 10.1002/14651858.CD000980.pub4; PUBMED: 23440782]
26. Hemilä H. Vitamin C may alleviate exercise-induced bronchoconstriction: a meta-analysis. BMJ Open 2013;3(6):e002416. [DOI: 10.1136/bmjopen-2012-002416; PUBMED: 23794586]
27. Hemilä H, Louhiala P. Vitamin C for preventing and treating pneumonia. Cochrane Database of Systematic Reviews 2013, Issue 8. [DOI: 10.1002/14651858.CD005532.pub3; PUBMED: 23925826]
28. Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analysis. BMJ 2003;327(7414):557-60. [DOI: 10.1136/bmj.327.7414.557; PUBMED: 12958120]
29. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1 [updated March 2011]. Vol. section 8.3.3, The Cochrane Collaboration, 2011.
30. Hrobjartsson A, Gotzsche PC. Placebo interventions for all clinical conditions. Cochrane Database of Systematic Reviews 2010, Issue 1. [DOI: 10.1002/14651858.CD003974.pub3; PUBMED: 20091554]
31. IOM (Institute of Medicine). Vitamin C. Dietary reference intakes for vitamin C, vitamin E, selenium and carotenoids. Washington DC: National Academy Press, 2000:95-185.
32. Kato K, Fukuma N, Kimura-Kato Y, Aisu N, Tuchida T, Mabuchi K. Improvement of sympathetic response to exercise by oral administration of ascorbic acid in patients after myocardial infarction. International Journal of Cardiology 2006;111(2):240-6. [DOI: 10.1016/j.ijcard.2005.07.020; PUBMED: 16246442]
33. Khan AA, Zahidie A, Rabbani F. Interventions to reduce neonatal mortality from neonatal tetanus in low and middle income countries--a systematic review. BMC Public Health 2013;13:322. [DOI: 10.1186/1471-2458-13-322; PUBMED: 23570611]
34. Klenner FR. Recent discoveries in the treatment of lockjaw with vitamin C and tolserol. Tri-State Medical Journal 1954;2(July):7-11. [http://www.mv.helsinki.fi/home/hemila/CT/Klenner1954.pdf]
35. Levine M, Conry-Cantilena C, Wang Y, Welch RW, Washko PW, Dhariwal KR, et al. Vitamin C pharmacokinetics in healthy volunteers: evidence for a recommended dietary allowance. Proceedings of the National Academy of Sciences of the USA 1996;93(8):3704-9. [DOI: 10.1073/pnas.93.8.3704; PUBMED: 8623000]
36. Levy TE. Vitamin C, Infectious Diseases, and Toxins. Xlibris, 2002.
37. Nathens AB, NeffMJ, Jurkovich GJ, Klotz P, Farver K, Ruzinski JT, et al. Randomized, prospective trial of antioxidant supplementation in critically ill surgical patients. Annals of Surgery 2002;236(6):814-22. [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1422648/]
38. Padayatty SJ, Sun H, Wang Y, Riordan HD, Hewitt SM, Katz A, et al. Vitamin C pharmacokinetics: implications for oral and intravenous use. Annals of Internal Medicine 2004;140(7):533-7. [DOI: 10.7326/0003-4819-140-7-200404060-00010; PUBMED: 15068981]
39. Padayatty SJ, Riordan HD, Hewitt SM, Katz A, Hoffer LJ, Levine M. Intravenously administered vitamin C as cancer therapy: three cases. CMAJ 2006;174(7):937-42. [DOI: 10.1503/cmaj.050346; PUBMED: 16567755]
40. Padayatty SJ, Sun AY, Chen Q, Espey MG, Drisko J, Levine M. Vitamin C: intravenous use by complementary and alternative medicine practitioners and adverse effects. PLoS One 2010;5(7):e11414. [DOI: 10.1371/journal.pone.0011414; PUBMED: 20628650]
41. Papoulidis P, Ananiadou O, Chalvatzoulis E, Ampatzidou F, Koutsogiannidis C, Karaiskos T, et al. The role of ascorbic acid in the prevention of atrial fibrillation after elective on-pump myocardial revascularization surgery: a single-center experience--a pilot study. Interactive Cardiovascular and Thoracic Surgery 2011;12(2):121-4. [DOI: 10.1510/icvts.2010.240473; PUBMED: 21098510]
42. Patak P, Willenberg HS, Bornstein SR. Vitamin C is an important cofactor for both adrenal cortex and adrenal medulla. Endocrine Research 2004;30(4):871-5. [DOI: 10.1081/ERC-200044126; PUBMED: 15666839]
43. Qin F, Rounds NK, Mao W, Kawai K, Liang CS. Antioxidant vitamins prevent cardiomyocyte apoptosis produced by norepinephrine infusion in ferrets. Cardiovascular Research 2001;51(4):736-48.
44. http://www.r-project.org/. The R Project for Statistical Computing. http://www.r-project.org/, 2013.
45. Reddy P, Bleck TP. Clostridium tetani (tetanus). In: Mandell GL, Bennett JE, Dolin R editor(s). Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. 7th Edition. Vol. 2, Philadelphia: Elsevier Churchill Livingstone, 2010:3091-6.
46. The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager. 5.2. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2012.
47. Rice ME. Ascorbate regulation and its neuroprotective role in the brain. Trends in Neurological Sciences 2000;23(5):209-16. [DOI: 10.1016/S0166-2236(99)01543-X; PUBMED: 10782126]
48. Rothman KJ, Greenland S. Small sample statistics for pure count data. Modern Epidemiology. 2nd Edition. London: Lippincott, Williams, Wilkins, 1998:250-2.
49. Sesso HD, Buring JE, Christen WG, Kurth T, Belanger C, MacFadyen J, et al. Vitamins E and C in the prevention of cardiovascular disease in men: the Physicians' Health Study II randomized controlled trial. JAMA 2008;300(18):2123-33. [DOI: 10.1001/jama.2008.600; PUBMED: 18997197]
50. Stone I. The Healing Factor. Vitamin C Against Disease. New York, NY: Grosset & Dunlap, 1972.
51. Tanaka H, Matsuda T, Miyagantani Y, Yukioka T, Matsuda H, Shimazaki S. Reduction of resuscitation fluid volumes in severely burned patients using ascorbic acid administration: a randomized, prospective study. Archives of Surgery 2000;135(3):326-31. [DOI: 10.1001/archsurg.135.3.326; PUBMED: 10722036]
52. Thwaites CL, Yen LM, Glover C, Tuan PQ, Nga NT, Parry J, et al. Predicting the clinical outcome of tetanus: the tetanus severity score. Tropical Medicine and International Health 2006;11(3):279-87. [DOI: 10.1111/j.1365-3156.2006.01562.x; PUBMED: 16553907]
53. Thwaites CL, Yen LM, Cordon SM, Binh NT, Nga N, White NJ, et al. Urinary catecholamine excretion in tetanus. Anaesthesia 2006;61(4):355-9. [DOI: 10.1111/j.1365-2044.2006.04580.x; PUBMED: 16548955]
54. Wasay M, Khealani BA, Talati N, Shamsi R, Syed NA, Salahuddin N. Autonomic nervous system dysfunction predicts poor prognosis in patients with mild to moderate tetanus. BMC Neurology 2005;5(1):2. [DOI: 10.1186/1471-2377-5-2; PUBMED: 15679900]
55. Webb AL, Villamor E. Update: effects of antioxidant and non-antioxidant vitamin supplementation on immune function. Nutrition Reviews 2007;65(5):181-217. [DOI: 10.1111/j.1753-4887.2007.tb00298.x; PUBMED: 17566547]
56. WHO. Recent outbreaks of scurvy. Scurvy and its prevention and control in major emergencies. WHO/NHD/99.11. WHO, 1999:1-4 (Table 2). [http://whqlibdoc.who.int/hq/1999/WHO_NHD_99.11.pdf]
57. WHO (World Health Organization). Maternal and neonatal tetanus elimination by 2005. Annex C; 2000:27. [http://www.unicef.org/health/files/MNTE_strategy_paper.pdf]
58. WHO (World Health Organization). Tetanus. http://www.who.int/topics/tetanus/en/2013.
59. Yuan L, Lau W, Thipphawong J, Kasenda M, Xie F, Bevilacqua J. Diphtheria and tetanus immunity among blood donors in Toronto. CMAJ 1997;156(7):985-90. [PUBMED: 9099166]
60. Hemilä H, Koivula T. Vitamin C for preventing and treating tetanus. Cochrane Database of Systematic Reviews 2008, Issue 2. [DOI: 10.1002/14651858.CD006665.pub2; PUBMED: 18425960]
61. Hemilä H, Koivula T. Vitamin C for preventing and treating tetanus. Cochrane Database of Systematic Reviews 2010, Issue 2. [DOI: 10.1002/14651858.CD006665.pub2]
62. Hemilä H, Koivula T. Vitamin C for preventing and treating tetanus. Cochrane Database of Systematic Reviews 2011, Issue 10. [DOI: 10.1002/14651858.CD006665.pub2]